Redsense Medical has secured its largest single order to date, valued at MSEK 3.7, from one of the company's US distributors.

"We are very excited about this important order for the US market. This large order gives us an excellent start of the fourth quarter. Given the challenging situation during the pandemic and the aftermath, this is a significant step in the right direction. Furthermore, this proves our strong focus on providing patient safety and the confidence that our customers place in our products" says Pontus Nobréus CEO of Redsense Medical AB.

"We continue our clear focus in the US, by showcasing our products and promoting patient safety during hemodialysis. In addition, we are working with our supply chain and distributing partners to secure the most efficient order flow and work towards consistent purchase patterns" continues Pontus Nobréus.

This information is information that Redsense Medical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out below, on October 18, 2022.